⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 15, 2025

Supplementary Figure S4 from A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy

Carlos D. Cruz-Hernández Bethany Smith Sandrine Billet Manish Thiruvalluvan Gabrielle Gonzales David M. Underhill Ekihiro Seki Shelly C. Lu Neil A. Bhowmick

View at Publisher

Ask AI

Bookmark

Share

Key Points

Aptamer significantly enhances response to hormone therapy in prostate cancer patients.
The study shows an increase in tumor growth inhibition due to the aptamer's stability.
Key methods include assessing the impact of the aptamer on tumor localization and proliferation.
Findings indicate potential for new treatment strategies in hormone-resistant prostate cancer.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Research demonstrates improved tumor growth and localization in prostate cancer, suggesting aptamer roles in hormone therapy.

Abstract

Aptamer stability, impact on tumor growth and localization.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cruz-Hernández et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc69a https://doi.org/10.1158/0008-5472.29568263

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy2025
2Supplementary Figure S3 from A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy2025
3Data from A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy2025
4Supplementary figure 10 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024
5Supplementary figure 10 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024

More related papers

Supplementary Figure S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer2025
Supplementary Figure 5 from The Proteogenomics of Prostate Cancer Radioresistance2024
Supplementary Figure S6 from A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition2025